Vitamin K2 (Menaquinone) Deficiency

What is Vitamin K2 (Menaquinone) Deficiency?

Vitamin K2 deficiency describes a shortfall of the menaquinone family of vitamin K compounds, the forms of the vitamin that dominate in fermented foods, animal tissues and the output of gut bacteria. It sits alongside, but is not identical to, the broader picture covered on our live Vitamin K Deficiency page — readers who want the whole-vitamin overview, including classical bleeding deficiency and vitamin K deficiency bleeding of the newborn, should start there. This document deals only with the K2 side of the split.

Vitamin K exists in two main natural branches. Vitamin K1 (phylloquinone) comes from green leaves and is taken up efficiently by the liver, where it drives the clotting factors. Vitamin K2 (menaquinones) is a family named by side-chain length — MK-4 through roughly MK-13. The two most discussed are MK-4, made in small amounts by the body from K1 and found in animal foods, and MK-7, produced by bacterial fermentation and famously concentrated in Japanese natto. Menaquinones with long side chains circulate far longer than K1 and reach tissues outside the liver more readily — bone, artery wall, cartilage, kidney.

Why the distinction matters

Vitamin K of any form acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which adds a carboxyl group to specific glutamate residues on a small set of proteins. That carboxylation is what lets those proteins bind calcium. In the liver the targets are clotting factors II, VII, IX and X. Outside the liver the targets include osteocalcin in bone and matrix Gla protein (MGP) in blood vessel walls and cartilage.

The body appears to prioritise the liver. When vitamin K is scarce, hepatic clotting carboxylation is defended and the extra-hepatic proteins are shortchanged first. This is the crux of the K2 story: a person can have an entirely normal prothrombin time and INR while carrying a meaningful population of undercarboxylated osteocalcin and undercarboxylated matrix Gla protein. That state — sometimes called subclinical or tissue-level vitamin K insufficiency — is common in Western populations and is what most people mean when they say K2 deficiency. Frank bleeding from K2 shortage alone is rare in adults with an intact gut and no drug interference.

Gut bacteria synthesise menaquinones, mainly long-chain forms, in the colon. How much of this the body actually absorbs is genuinely uncertain; colonic absorption of a fat-soluble vitamin without bile salts is probably modest, so bacterial production should not be assumed to cover requirements. Dietary intake in most Western diets is low, dominated by MK-4 from meat, egg yolk, butter and organ meats, plus whatever fermented food a person eats.

The warfarin point, stated plainly

Warfarin and other coumarin anticoagulants work precisely by blocking vitamin K recycling. Any vitamin K2 supplement — MK-4 or MK-7 — directly opposes the drug and can push INR down and clotting risk up. This is not a theoretical interaction. Anyone on warfarin, acenocoumarol or phenprocoumon must not start a K2 supplement without their anticoagulation clinic managing it.

What are the Signs and Symptoms of Vitamin K2 Deficiency?

Low vitamin K2 status is usually silent. Unlike iron or B12 deficiency, there is no reliable symptom set that tells a person their menaquinone intake is inadequate. What follows separates the honest categories: the rare frank findings, the indirect and non-specific findings, and the things sometimes attributed to K2 on thin ground.

Findings of overt vitamin K deficiency (any form)

• Easy bruising, or bruises appearing without remembered injury
• Bleeding gums when brushing, or frequent nosebleeds
• Prolonged oozing from small cuts, dental extractions or venepuncture sites
• Heavier than usual menstrual bleeding
• Blood in urine or dark, tarry stools — always a reason to seek care promptly
• In newborns, unexplained bleeding — covered on the main Vitamin K Deficiency page

These reflect depleted hepatic vitamin K generally, not menaquinone specifically, and appear only when total vitamin K supply is very low or when a drug, malabsorption or liver disease is in play.

Indirect, non-specific findings associated with low K2 status

• Low bone mineral density on DEXA scanning that is out of proportion to age, calcium and vitamin D status
• Fragility fractures — wrist, hip, vertebral — from minor falls
• Loss of height or a developing thoracic curve from vertebral compression
• Arterial calcification noted incidentally on imaging, such as coronary calcium on a CT scan or aortic calcification on a chest or abdominal X-ray
• Calcification of the aortic valve or mitral annulus found on echocardiography
• Dental findings some clinicians associate with poor mineral handling — increased caries, enamel problems — though the K2 link here is speculative

Every item on that list has many causes. Arterial calcification, in particular, is driven by age, kidney function, diabetes, smoking and lipids far more than by any single vitamin. Low K2 status is best thought of as one contributing thread, not the explanation.

Claims that outrun the evidence

K2 is sometimes credited with resolving fatigue, altering facial bone structure in adults, reversing established atherosclerosis, or acting as a general anti-ageing agent. None of these is supported. Framing a symptom as a K2 deficiency sign when it is not delays the correct diagnosis.

When the picture points somewhere else

• Bruising plus fatigue plus recurrent infection needs a full blood count, not a supplement
• Bleeding with jaundice, pale stools or alcohol history points to liver or bile problems
• Chronic diarrhoea with weight loss suggests fat malabsorption, which affects all fat-soluble vitamins together
• Sudden severe bone pain after minimal trauma warrants imaging

Who is Most at Risk of Low Vitamin K2 Status?

Dietary patterns

• Western diets with little or no fermented food — the single commonest reason for low menaquinone intake
• Strict vegan diets without natto, tempeh or fermented vegetables, since MK-4 sources are all animal-derived
• Long-term low-fat eating, which reduces both intake and absorption
• Diets built on refined and ultra-processed food with few greens, eggs or dairy
• Avoidance of whole eggs, butter and full-fat dairy for cholesterol reasons

Absorption and gut factors

• Coeliac disease, Crohn disease and ulcerative colitis
• Chronic pancreatitis and pancreatic insufficiency
• Cystic fibrosis
• Bile duct obstruction, primary biliary cholangitis, cholestasis, or gallbladder removal with ongoing fat intolerance
• Bariatric surgery, particularly bypass procedures that shorten the absorptive route
• Short bowel syndrome and extensive bowel resection
• Small intestinal bacterial overgrowth and other states that disrupt normal flora

Medications

• Warfarin and other coumarin anticoagulants — these deliberately block vitamin K recycling, so long-term users carry a high undercarboxylated protein burden by design. This is a recognised trade-off of the therapy, not a fault to correct on your own.
• Repeated or prolonged broad-spectrum antibiotics, which suppress menaquinone-producing colonic bacteria
• Bile acid sequestrants such as colestyramine and colesevelam
• Orlistat and other fat absorption blockers
• Long-term high-dose vitamin E, which can interfere with vitamin K activity
• Some anticonvulsants, which alter vitamin K metabolism

Life stage and health status

• Older adults — lower intake, less efficient absorption, and higher fracture and calcification risk at the same time
• Newborns — born with very low vitamin K stores; this is addressed on the main Vitamin K Deficiency page and is managed with routine vitamin K1 at birth
• Postmenopausal women, because oestrogen loss accelerates bone turnover
• Chronic kidney disease and dialysis, a group with both low vitamin K status and pronounced vascular calcification
• Type 2 diabetes and metabolic syndrome
• Chronic liver disease, which impairs both storage and use
• People on long-term high-dose calcium supplements without attention to vitamin K and D status
• Heavy alcohol use, through combined liver, pancreatic and dietary effects

How is Vitamin K2 Status Tested?

There is no single routine blood test that reports vitamin K2 status the way a ferritin reports iron. Testing here is a compromise between what is available, what is meaningful and what is affordable. Reference ranges differ substantially between laboratories and assay methods, so always read the range printed on your own report rather than one quoted online.

Functional markers — the most informative group

• Undercarboxylated osteocalcin (ucOC), or the ratio of ucOC to total osteocalcin — osteocalcin is the vitamin K dependent protein of bone. A high undercarboxylated fraction indicates that bone-level carboxylation is not being fully supported. This is the closest thing to a bone-specific vitamin K status marker, and it responds to menaquinone intake within weeks.
• Dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) — the vascular counterpart. Matrix Gla protein is the main local inhibitor of calcification in artery walls. Elevated dp-ucMGP means circulating MGP is inactive, and it falls reliably with vitamin K2 supplementation. Mostly a research and specialist assay; availability varies by country.
• PIVKA-II (protein induced by vitamin K absence, factor II) — the liver marker. Detectable PIVKA-II means hepatic vitamin K is genuinely inadequate. It is more sensitive than INR but still reflects the liver pool, which is defended last to fail.

Clotting tests — useful but blunt

• Prothrombin time and INR — only become abnormal when hepatic vitamin K is substantially depleted. A completely normal INR does not rule out low tissue-level K2 status. Do not use a normal INR as reassurance about bone or vascular vitamin K.
• Full blood count and platelet count — ordered when there is bruising or bleeding, to exclude platelet and marrow causes.

Direct measurement

• Serum phylloquinone (K1) — sometimes offered, but it swings with the last meal and does not describe menaquinone status at all.
• Serum MK-4 and MK-7 — specialist assays, short half-life for MK-4, and not standardised for clinical decisions.

Tests that help interpret the picture

• Liver function tests and bile-related markers, since bile is required for absorption of all fat-soluble vitamins
• Coeliac serology, faecal elastase or faecal fat if malabsorption is suspected
• Serum 25-hydroxyvitamin D, calcium, phosphate and parathyroid hormone — vitamin D and K interact in calcium handling and should be read together
• Kidney function, including eGFR, because chronic kidney disease strongly influences vascular calcification and dp-ucMGP
• DEXA bone density scanning where fracture risk is the concern

A reasonable practical approach for most people: rather than chasing an assay that a general practice cannot order, assess dietary menaquinone intake, review medications including any anticoagulant, and check the standard bone and kidney panel. Order ucOC or dp-ucMGP only when a clinician will actually change management on the result.

How Can Vitamin K2 Status Be Improved Naturally?

The strategy is straightforward: raise menaquinone intake, make sure it can be absorbed, and address anything that is draining or blocking vitamin K. Nothing here is a treatment for osteoporosis or vascular disease in its own right, and no supplement should replace treatment a clinician has prescribed for those conditions.

Food-first steps

• Add a fermented food most days — natto if you can tolerate it, otherwise aged Gouda, Edam or a comparable hard cheese, sauerkraut, kimchi or tempeh
• Keep whole eggs, full-fat dairy and butter in the diet rather than avoiding them reflexively
• Include liver occasionally — once a fortnight is enough to matter, and avoid liver in pregnancy because of its vitamin A load
• Eat leafy greens daily with some fat, both for K1 itself and as substrate for tissue MK-4 conversion
• Do not fear dietary fat at these meals — fat-soluble vitamins need it

Supplement forms, described neutrally

• MK-7 — long half-life, so once-daily dosing works. Typical supplement amounts fall in the range of roughly 90 to 180 micrograms daily; this is the form used in most bone and vascular marker studies. Look for products stating the trans isomer, as the cis form is inactive.
• MK-4 — short half-life, so it is usually given in much larger doses and multiple times daily in the studies that used it. Standard low-dose MK-4 products behave quite differently from those study protocols.
• Combined K1 plus K2 products — reasonable if diet is poor in both.
• Vitamin D and K2 combinations — popular, and biologically coherent because vitamin D raises calcium absorption while vitamin K dependent proteins direct where calcium is deposited. That coherence is mechanistic reasoning, not proof of an outcome benefit.

Supporting the absorption pathway

• Take supplements with the largest fatty meal of the day
• Address untreated coeliac disease, chronic pancreatitis or bile flow problems with a clinician — these limit every fat-soluble vitamin
• Review long-term bile acid sequestrants, orlistat and repeated broad-spectrum antibiotic courses with a prescriber
• Support a diverse gut flora with fibre and fermented foods; bacterial menaquinone production is one contributor even if absorption from the colon is limited

Cautions that must not be skipped

• Warfarin, acenocoumarol and phenprocoumon — K2 directly antagonises these drugs. Do not self-start. If a K2 supplement is ever appropriate, the anticoagulation service must set a fixed daily dose and monitor INR closely, and the dose must never be changed or stopped without them.
• Direct oral anticoagulants such as apixaban and rivaroxaban do not work through vitamin K, but tell the prescriber anyway
• Pregnancy, breastfeeding, active kidney disease and dialysis — discuss before supplementing

Timescale: functional markers such as undercarboxylated osteocalcin and dp-ucMGP typically shift within four to twelve weeks of consistent intake. Structural outcomes like bone density change over years, if at all.

Which Foods Provide Vitamin K2?

Vitamin K2 content in food is far more variable than K1, because it depends on bacterial fermentation, animal feeding and the specific microbes involved. Two cheeses of the same name from different producers can differ several-fold. Treat the figures you see anywhere as approximations.

Fermented foods — the long-chain sources

• Natto — fermented soybeans made with Bacillus subtilis. By a wide margin the richest known food source of MK-7, containing many times more than anything else on this list. A small daily portion, around 40 to 50 grams, covers menaquinone needs comfortably. Strong smell and sticky texture put many people off, but no other food comes close.
• Hard and semi-hard aged cheeses — Gouda, Edam, Jarlsberg, Emmental, aged Cheddar. These supply mainly MK-8 and MK-9 from the starter cultures, with some MK-4. Aged and washed-rind cheeses tend to have more than fresh cheeses.
• Soft ripened cheeses — Brie, Camembert and blue cheeses contribute meaningful amounts.
• Curd cheese, quark and traditional cultured buttermilk — modest amounts.
• Sauerkraut and other lactic-fermented vegetables — small but real menaquinone content, higher in traditionally fermented versions than pasteurised jars.

Animal foods — the MK-4 sources

• Goose liver and other liver — among the densest MK-4 sources
• Egg yolks — content rises with pasture access and feed quality; two yolks a day is a practical contribution
• Butter and ghee, especially from grass-fed animals
• Full-fat dairy — cream, whole milk, full-fat yoghurt
• Chicken with skin, dark chicken meat and chicken liver
• Fatty cuts of pork and beef, and bone marrow
• Emu, duck and other poultry fats

Practical points about absorption

• All menaquinones are fat soluble — they need dietary fat and adequate bile for uptake. Eating them as part of a normal meal is enough.
• Very low-fat diets, long-term bile duct obstruction and fat malabsorption reduce uptake of every form of vitamin K.
• MK-7 stays in circulation far longer than MK-4 or K1, which is why natto and MK-7 supplements affect tissue markers so efficiently. MK-4 clears within hours.
• Cooking does not destroy menaquinones appreciably. Pasteurisation of fermented foods does not remove the vitamin already made, but stopping active fermentation means no further production.
• Eating K1-rich greens still matters. The body converts some K1 to MK-4 in tissues, and greens are the dominant source of total vitamin K in most diets.

If you eat no animal products and no natto

A strict vegan diet without natto or fermented vegetables is close to menaquinone-free. Options are natto, tempeh and other fermented soy in quantity, sauerkraut and kimchi, vegan MK-7 supplements produced by bacterial fermentation, plus generous K1 from greens.

What Happens if Vitamin K2 Deficiency is Left Unaddressed?

The consequences of long-term low menaquinone status are slow, quiet and largely structural. Because the liver defends its own clotting supply first, most people with poor K2 status will never see an abnormal INR — and that is exactly why the problem goes unnoticed. What accumulates instead is a shortfall in the carboxylation of the vitamin K dependent proteins that manage calcium outside the liver.

In bone, osteocalcin that is not fully carboxylated cannot bind calcium into the mineral matrix effectively. A persistently high undercarboxylated osteocalcin fraction has been associated in observational research with lower bone mineral density and higher hip fracture risk in older adults, independent of calcium and vitamin D intake. This is association rather than proof of causation, and trial results on fracture prevention have been mixed — some Japanese studies using high-dose MK-4 showed fracture benefit, while several Western MK-7 trials showed marker improvement with little change in bone density. The honest summary is that low K2 status is plausibly one contributor to fragility fracture risk among many, and that treating it does not substitute for osteoporosis management.

In the vascular system, matrix Gla protein is the principal local brake on calcium deposition in artery walls and heart valves. Without adequate vitamin K it stays inactive, and elevated dp-ucMGP has been linked in cohort studies with arterial stiffness, coronary artery calcium, aortic valve calcification and cardiovascular mortality, most strikingly in people with chronic kidney disease. Supplementation reliably lowers dp-ucMGP; whether that translates into fewer cardiovascular events remains unproven, and trials designed to slow established calcification have been largely disappointing. Nobody should expect a supplement to reverse calcification already present.

Other consequences are less well mapped. Cartilage contains vitamin K dependent proteins, and low status has been associated with osteoarthritis features in observational work. Dental and periodontal links are frequently claimed but poorly supported. In severe, combined vitamin K depletion — usually from malabsorption, biliary disease or drug effects rather than diet alone — the classical bleeding picture eventually appears: bruising, mucosal bleeding, and in rare untreated cases serious haemorrhage. That end of the spectrum belongs to total vitamin K depletion and is covered on the main Vitamin K Deficiency page.

The practical takeaway is one of patience and proportion. Correcting menaquinone intake shifts laboratory markers within weeks, but any structural benefit is measured in years, is modest, and works only alongside adequate protein, calcium, vitamin D, weight-bearing activity and control of the conditions that actually drive bone loss and calcification. And for anyone taking warfarin, changing vitamin K intake without the anticoagulation clinic can destabilise INR, which is a far more immediate risk than the deficiency itself.